Inicio > Term: daclizumab
daclizumab
A monoclonal antibody that is being studied in the treatment of adult T-cell leukemia and in the treatment of cytopenia (low blood cell count). Also called dacliximab.
- Parte del discurso: noun
- Industria/ámbito: Asistencia sanitaria
- Categoría: Tratamiento del cáncer
- Company: U.S. HHS
0
Creador
- Lionel M
-
(Platinum) 5532 puntos - 100% positive feedback
